Search
Browse
Statistics
Feeds

Prevascularized grafts with spatially organized MSC spheroids to accelerate therapeutic angiogenesis in ischemic disease

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
9MB
[thumbnail of Supplementary Information] MS Word (Supplementary Information)
12MB

Item Type:Article
Title:Prevascularized grafts with spatially organized MSC spheroids to accelerate therapeutic angiogenesis in ischemic disease
Creators Name:Son, Jeonghyun, Naren, Aruzhan, Mohamed, Hanan Jamal, Ahn, Minjun, Ha, Won, Kim, Min Kyeong, Jeon, Seunggyu, Kim, Byoung Soo, Cho, Yoon-Kyoung, Takeuchi, Shoji and Kang, Hyun-Wook
Abstract:OBJECTIVE: Ischemic diseases, characterized by impaired blood flow and progressive tissue necrosis, remain a major challenge in regenerative medicine. Surgical revascularization remains the gold standard for restoring blood flow in major vessels, but still shows limited effects on microvascular regeneration. To address this unmet need, various strategies in therapeutic angiogenesis have been explored to induce microvascular formation, including delivery of bioactive molecules, stem cells, or pre-vascularized grafts. However, injection-based approaches often suffer from off-target effects, and conventional implantable grafts lack sufficient angiogenic secretory activity. To address these limitations, we aimed to develop a dual-function prevascularized graft that accelerates neovascularization and promotes vascular integration to restore tissue perfusion in ischemic conditions. METHODS AND RESULTS: The graft was engineered by combining a microvascular pattern (µVP) with spatially organized mesenchymal stem cell (MSC) spheroids, fabricated via high-precision coprinting of endothelial cells and MSCs. Optimization of spheroid density and spatial arrangement enhanced VEGF secretion and increased host capillary infiltration nearly two-fold. In a murine critical limb ischemia model, implantation of these engineered grafts achieved a 60% limb salvage rate and reduced limb loss by ~ 15%, representing a 4.5-fold improvement over conventional grafts. Histological and morphometric analyses confirmed reduced muscle degeneration, enhanced neovascularization, and seamless anastomosis between engineered and host vessels. CONCLUSIONS: These findings demonstrate a dual-functional graft that couples paracrine stimulation with structural vascular support, providing a promising regenerative strategy to promote therapeutic angiogenesis and ischemia therapy, while indicating its potential for preclinical and future clinical applications in ischemic disease.
Keywords:Regenerative Medicine, Ischemia Therapy, Therapeutic Angiogenesis, Prevascularized Grafts, Mesenchymal Stem Cell Spheroids, Animals, Mice
Source:Angiogenesis
ISSN:0969-6970
Publisher:Springer
Volume:29
Number:3
Page Range:38
Date:9 June 2026
Official Publication:https://doi.org/10.1007/s10456-026-10059-3
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library